LARUE WILLIAM R
Insider CIK 1265784 · ONCT Director · CADX SVP, CFO, Treas, Asst Sec · CNAT Director · TCON Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONCT Oncternal Therapeutics, In | A Award deriv | 2024-06-20 | 2024-06-24 | 2,200 | — | $0 | 2,200 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-06-28 | 2023-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2023-04-19 | 2023-04-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | S Sale | 2022-12-21 | 2023-01-19 | 120 | $1.26 | $151 | 7,763 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-06-16 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2022-06-14 | 2022-06-16 | 15,750 | — | $0 | 15,750 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2021-07-26 | 2021-07-27 | 6,545 | $3.82 | $25.0K | 7,883 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2021-06-10 | 2021-06-24 | 10,500 | — | $0 | 10,500 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2021-05-25 | 2021-05-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-06-11 | 2020-07-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-06-11 | 2020-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2020-06-10 | 2020-06-16 | 4,500 | — | $0 | 4,500 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2020-07-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2019-09-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-06-27 | 2019-07-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2019-06-13 | 2019-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONCT GTX INC /DE/ | A Award deriv | 2019-06-07 | 2019-06-11 | 281 | — | $0 | 281 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 10,030 | — | $0 | 10,030 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 16,144 | — | $0 | 16,144 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2018-06-13 | 2018-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2017-06-15 | 2017-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | S Sale | 2017-06-02 | 2017-06-05 | 2,500 | $2.69 | $6.7K | 13,388 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2017-02-06 | 2017-02-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award | 2016-06-01 | 2016-06-02 | 7,500 | — | $0 | 15,888 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2015-07-23 | 2015-07-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | A Award deriv | 2015-07-23 | 2015-07-24 | 12,547 | — | $0 | 12,547 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 50,000 | $4.78 | $239.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 113,750 | $10.80 | $1.23M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 100,000 | $14.00 | $1.40M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 115,000 | $8.60 | $989.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 62,949 | $10.49 | $660.3K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 150,000 | $10.49 | $1.57M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 125,000 | $5.45 | $681.3K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 15,000 | $4.78 | $71.7K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 63,000 | $5.65 | $355.9K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 60,000 | $7.99 | $479.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 45,000 | — | $0 | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 37,500 | $10.80 | $405.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 11,000 | $14.00 | $154.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 5,000 | $14.00 | $70.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2014-02-10 | 2014-02-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-12-17 | 2013-12-18 | 8,500 | — | $0 | 113,750 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-12-17 | 2013-12-18 | 8,500 | $3.20 | $27.2K | 13,500 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-12-17 | 2013-12-18 | 8,500 | $9.12 | $77.5K | 5,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-11-18 | 2013-11-18 | 9,000 | — | $0 | 122,250 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-11-18 | 2013-11-18 | 9,000 | $3.20 | $28.8K | 14,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-11-18 | 2013-11-18 | 9,000 | $7.60 | $68.4K | 5,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-11-15 | 2013-11-18 | 27,000 | — | $0 | 131,250 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-11-15 | 2013-11-18 | 27,000 | $7.20 | $194.4K | 5,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-11-15 | 2013-11-18 | 27,000 | $3.20 | $86.4K | 32,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-07-17 | 2013-07-17 | 9,000 | — | $0 | 158,250 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-07-17 | 2013-07-17 | 9,000 | $3.20 | $28.8K | 14,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-07-17 | 2013-07-17 | 9,000 | $7.26 | $65.3K | 5,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-06-27 | 2013-06-27 | 5,740 | — | $0 | 167,250 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-06-27 | 2013-06-27 | 5,740 | $3.20 | $18.4K | 10,740 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-06-27 | 2013-06-27 | 5,740 | $7.20 | $41.3K | 5,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-06-25 | 2013-06-27 | 3,260 | — | $0 | 172,990 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-06-25 | 2013-06-27 | 3,260 | $7.20 | $23.5K | 5,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-06-25 | 2013-06-27 | 3,260 | $3.20 | $10.4K | 8,260 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2013-03-13 | 2013-03-15 | 115,000 | — | $0 | 115,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 62,949 | — | $0 | 62,949 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-03-14 | 2012-03-16 | 150,000 | — | $0 | 150,000 | SEC↗ |